Literature DB >> 17479202

The Marburg I polymorphism of factor VII-activating protease and the risk of venous thromboembolism.

Volker Weisbach, Renate Ruppel, Reinhold Eckstein.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17479202     DOI： 10.1160/th06-12-0739

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN： 0340-6245            Impact factor:   5.249


× No keyword cloud information.
  4 in total

1.  Whole-exome sequencing in evaluation of patients with venous thromboembolism.

Authors:  Eun-Ju Lee; Daniel J Dykas; Andrew D Leavitt; Rodney M Camire; Eduard Ebberink; Pablo García de Frutos; Kavitha Gnanasambandan; Sean X Gu; James A Huntington; Steven R Lentz; Koen Mertens; Christopher R Parish; Alireza R Rezaie; Peter P Sayeski; Caroline Cromwell; Noffar Bar; Stephanie Halene; Natalia Neparidze; Terri L Parker; Adrienne J Burns; Anne Dumont; Xiaopan Yao; Cassius Iyad Ochoa Chaar; Jean M Connors; Allen E Bale; Alfred Ian Lee
Journal:  Blood Adv       Date:  2017-06-29

2.  Factor VII-activating protease promotes the proteolysis and inhibition of tissue factor pathway inhibitor.

Authors:  Sandip M Kanse; Paul J Declerck; Wolfram Ruf; George Broze; Michael Etscheid
Journal:  Arterioscler Thromb Vasc Biol       Date:  2011-11-23       Impact factor: 8.311

3.  Role of glycine 221 in catalytic activity of hyaluronan-binding protein 2.

Authors:  Fabian Stavenuiter; Eduard H T M Ebberink; Koen Mertens; Alexander B Meijer
Journal:  J Biol Chem       Date:  2017-02-27       Impact factor: 5.157

4.  Germline HABP2 Mutation Causing Familial Nonmedullary Thyroid Cancer.

Authors:  Sudheer Kumar Gara; Li Jia; Maria J Merino; Sunita K Agarwal; Lisa Zhang; Maggie Cam; Dhaval Patel; Electron Kebebew
Journal:  N Engl J Med       Date:  2015-07-30       Impact factor: 91.245
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.